{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:07:57Z","timestamp":1764936477956},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T00:00:00Z","timestamp":1224460800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T00:00:00Z","timestamp":1224460800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1038\/bmt.2008.332","type":"journal-article","created":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T12:20:01Z","timestamp":1224505201000},"page":"773-781","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Hematopoietic SCT for peripheral T-cell lymphoma"],"prefix":"10.1038","volume":"42","author":[{"given":"A","family":"Guti\u00e9rrez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M D","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"P\u00e9rez-Manga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,20]]},"reference":[{"key":"BFbmt2008332_CR1","first-page":"177","volume":"12","author":"JK Chan","year":"1999","unstructured":"Chan JK . Peripheral T-cell and NK-cell neoplasms: an integrated approach to diagnosis. Mod Pathol 1999; 12: 177\u2013199.","journal-title":"Mod Pathol"},{"key":"BFbmt2008332_CR2","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"BFbmt2008332_CR3","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1182\/blood.V89.12.4514","volume":"89","author":"A Melnyk","year":"1997","unstructured":"Melnyk A, Rodriguez A, Pugh WC, Cabannillas F . Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997; 89: 4514\u20134520.","journal-title":"Blood"},{"key":"BFbmt2008332_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA et al. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 2002; 13: 140\u2013149.","journal-title":"Ann Oncol"},{"key":"BFbmt2008332_CR5","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V110.11.3452.3452","volume":"110","author":"AN AbouYabis","year":"2007","unstructured":"AbouYabis AN, Shenoy PJ, Flowers C, Lechowicz MJ . Response and survival rates in patients with peripheral T-cell lymphoma treated with anthracycline-based regimens: a comprehensive meta-analysis. Blood 2007; 110: 3452.","journal-title":"Blood"},{"key":"BFbmt2008332_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","volume":"15","author":"KJ Savage","year":"2004","unstructured":"Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM . Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004; 15: 1467\u20131475.","journal-title":"Ann Oncol"},{"key":"BFbmt2008332_CR7","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V110.11.3451.3451","volume":"110","author":"P Bierman","year":"2007","unstructured":"Bierman P, Vose JM, Bociek RG, Loberiza F, Bast M, Weisenburger DD et al. Outcome of limited-stage peripheral T-cell lymphoma: results from the Nebraska Lymphoma Study Group. Blood 2007; 110: 3451.","journal-title":"Blood"},{"key":"BFbmt2008332_CR8","doi-asserted-by":"publisher","first-page":"5496","DOI":"10.1182\/blood-2008-01-134270","volume":"111","author":"KJ Savage","year":"2008","unstructured":"Savage KJ, Harris NL, Vose JM, Ullrich F, Jaffe ES, Connors JM et al. ALK-negative anaplastic large-cell lymphoma (ALCL) is clinically and immunophenotypically different from both ALK-positive ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project. Blood 2008; 111: 5496\u20135504.","journal-title":"Blood"},{"key":"BFbmt2008332_CR9","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1002\/cncr.20999","volume":"103","author":"MP Escalon","year":"2005","unstructured":"Escalon MP, Liu NS, Yang Y, Hess M, Walker PL, Smith TL et al. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the MD Anderson Cancer Center experience. Cancer 2005; 103: 2091\u20132098.","journal-title":"Cancer"},{"key":"BFbmt2008332_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/sj.bmt.1702867","volume":"27","author":"AK Blystad","year":"2001","unstructured":"Blystad AK, Enblad G, Kvaloy S, Berglund A, Delabie J, Holte H et al. High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas. Bone Marrow Transplant 2001; 27: 711\u2013716.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008332_CR11","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdg008","volume":"14","author":"MD Caballero","year":"2003","unstructured":"Caballero MD, Perez-Simon JA, Iriondo A, Lahuerta JJ, Sierra J, Marin J et al. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 2003; 14: 140\u2013151.","journal-title":"Ann Oncol"},{"key":"BFbmt2008332_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2141.2006.06164.x","volume":"134","author":"T Kewalramani","year":"2006","unstructured":"Kewalramani T, Zelenetz AD, Teruya-Feldstein J, Hamlin P, Yahalom J, Horwitz S et al. Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma. Br J Haematol 2006; 134: 202\u2013207.","journal-title":"Br J Haematol"},{"key":"BFbmt2008332_CR13","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.bmt.1705752","volume":"40","author":"S Feyler","year":"2007","unstructured":"Feyler S, Prince HM, Pearce R, Towlson K, Nivison-Smith I, Schey S et al. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study. Bone Marrow Transplant 2007; 40: 443\u2013450.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008332_CR14","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3324\/haematol.11173","volume":"92","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Lahuerta JJ, Arranz R, Sureda A et al. The adjusted International Prognostic Index and beta-2-microglobulin predict the outcome after autologous stem cell transplantation in relapsing\/refractory peripheral T-cell lymphoma. Haematologica 2007; 92: 1067\u20131074.","journal-title":"Haematologica"},{"key":"BFbmt2008332_CR15","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1200\/JCO.2001.19.17.3766","volume":"19","author":"J Rodriguez","year":"2001","unstructured":"Rodriguez J, Munsell M, Yazji S, Hagemeister FB, Younes A, Andersson B et al. Impact of high-dose chemotherapy on peripheral T-cell lymphomas. J Clin Oncol 2001; 19: 3766\u20133770.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008332_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1046\/j.1365-2141.2003.04203.x","volume":"120","author":"KW Song","year":"2003","unstructured":"Song KW, Mollee P, Keating A, Crump M . Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype. Br J Haematol 2003; 120: 978\u2013985.","journal-title":"Br J Haematol"},{"key":"BFbmt2008332_CR17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/sj.bmt.1704367","volume":"33","author":"E Jantunen","year":"2004","unstructured":"Jantunen E, Wiklund T, Juvonen E, Putkonen M, Lehtinen T, Kuittinen O et al. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Bone Marrow Transplant 2004; 33: 405\u2013410.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008332_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.bmt.1705712","volume":"40","author":"SD Smith","year":"2007","unstructured":"Smith SD, Bolwell BJ, Rybicki LA, Brown S, Dean R, Kalaycio M et al. Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen. Bone Marrow Transplant 2007; 40: 239\u2013243.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008332_CR19","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/annonc\/mdl466","volume":"18","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J et al. The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience. Ann Oncol 2007; 18: 652\u2013657.","journal-title":"Ann Oncol"},{"key":"BFbmt2008332_CR20","first-page":"1372","volume":"88","author":"J Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, Gandarillas M, Sierra J, Lopez-Guillermo A et al. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience. Haematologica 2003; 88: 1372\u20131377.","journal-title":"Haematologica"},{"key":"BFbmt2008332_CR21","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/annonc\/mdg459","volume":"14","author":"J Rodriguez","year":"2003","unstructured":"Rodriguez J, Caballero MD, Gutierrez A, Marin J, Lahuerta JJ, Sureda A et al. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience. Ann Oncol 2003; 14: 1768\u20131775.","journal-title":"Ann Oncol"},{"key":"BFbmt2008332_CR22","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R, Bellei M, Mattei D, Vitolo U et al. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 2004; 103: 2474\u20132479.","journal-title":"Blood"},{"key":"BFbmt2008332_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1600-0609.2007.00815.x","volume":"78","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Gandarillas M, Leon A et al. Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation: the GELTAMO experience. Eur J Haematol 2007; 78: 290\u2013296.","journal-title":"Eur J Haematol"},{"key":"BFbmt2008332_CR24","first-page":"218","volume":"26","author":"C Kyriakou","year":"2008","unstructured":"Kyriakou C, Canals C, Goldstone A, Caballero D, Metzner B, Kobbe G et al. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol 2008; 26: 218\u2013224.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008332_CR25","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/sj.leu.2404306","volume":"20","author":"P Corradini","year":"2006","unstructured":"Corradini P, Tarella C, Zallio F, Dodero A, Zanni M, Valagussa P et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia 2006; 20: 1533\u20131538.","journal-title":"Leukemia"},{"key":"BFbmt2008332_CR26","doi-asserted-by":"crossref","first-page":"5431a","DOI":"10.1182\/blood.V108.11.5431.5431","volume":"108","author":"P Reimer","year":"2006","unstructured":"Reimer P, Ruediger T, Weissinger F, Mueller-Hermelink HK, Engert A, Einsele H et al. Different outcome for angioimmunoblastic T-cell lymphoma (AIL) and peripheral T-cell lymphoma unspecified (PTCL-U) following upfront autologous stem cell transplantation. Blood 2006; 108: 5431a.","journal-title":"Blood"},{"key":"BFbmt2008332_CR27","doi-asserted-by":"publisher","first-page":"401a","DOI":"10.1182\/blood-2005-09-3843","volume":"108","author":"F d\u2019Amore","year":"2006","unstructured":"d\u2019Amore F, Relander T, Lauritzsen G, Jantunen E, Hagberg H, Anderson H et al. Dose-dense induction followed by autologous stem cell transplant (ASCT) as 1st line treatment in peripheral T-cell lymphomas (PTCL)\u2014a Phase II Study of the Nordic Lymphoma Group (NLG). Blood 2006; 108: 401a.","journal-title":"Blood"},{"key":"BFbmt2008332_CR28","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1600-0609.2007.00856.x","volume":"79","author":"J Rodriguez","year":"2007","unstructured":"Rodriguez J, Conde E, Gutierrez A, Arranz R, Leon A, Marin J et al. Frontline autologous stem cell transplantation in high-risk peripheral T-cell lymphoma: a prospective study from The Gel-Tamo Study Group. Eur J Haematol 2007; 79: 32\u201338.","journal-title":"Eur J Haematol"},{"key":"BFbmt2008332_CR29","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/annonc\/mdn022","volume":"19","author":"S Mercadal","year":"2008","unstructured":"Mercadal S, Briones J, Xicoy B, Pedro C, Escoda L, Estany C et al. Intensive chemotherapy (high-dose CHOP\/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma. Ann Oncol 2008; 19: 958\u2013963.","journal-title":"Ann Oncol"},{"key":"BFbmt2008332_CR30","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/sj.thj.6200359","volume":"5","author":"P Reimer","year":"2004","unstructured":"Reimer P, Schertlin T, R\u00fcdiger T, Geissinger E, Roth S, Kunzmann V et al. Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study. Hematol J 2004; 5: 304\u2013311.","journal-title":"Hematol J"},{"key":"BFbmt2008332_CR31","doi-asserted-by":"publisher","first-page":"8515","DOI":"10.1200\/jco.2008.26.15_suppl.8515","volume":"26","author":"P Reimer","year":"2008","unstructured":"Reimer P, R\u00fcdiger T, Einsele H, Geissinger E, Weissinger F, Nerl C et al. Autologous stem cell transplantation (autoSCT) as first-line therapy in peripheral T cell lymphomas (PTCL): results of a prospective multicenter study. J Clin Oncol 2008; 26: 8515.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008332_CR32","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1200\/JCO.2001.19.5.1395","volume":"19","author":"A Sureda","year":"2001","unstructured":"Sureda A, Arranz R, Iriondo A, Carreras E, Lahuerta JJ, Garcia-Conde J et al. Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Gruppo Espanol de Linfomas\/Transplante Autologo de Medula Osea Spanish Cooperative Group. J Clin Oncol 2001; 19: 1395\u20131404.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008332_CR33","doi-asserted-by":"crossref","first-page":"3070a","DOI":"10.1182\/blood.V108.11.3070.3070","volume":"108","author":"S Mercadal","year":"2006","unstructured":"Mercadal S, Lopez-Guillermo A, Briones J, Xicoy B, Pedro C, Escoda L et al. Is there a role for autologous stem-cell transplantation (ASCT) in peripheral T-cell lymphoma (PTCL)? Final results of a prospective phase II study from the GELCAB. Blood 2006; 108: 3070a.","journal-title":"Blood"},{"key":"BFbmt2008332_CR34","doi-asserted-by":"publisher","first-page":"v15","DOI":"10.1093\/annonc\/mdi599","volume":"16","author":"F d\u2019Amore","year":"2005","unstructured":"d\u2019Amore F . High-dose therapy and autologous stem cell transplant as first line treatment in peripheral T-cell lymphomas. Ann Oncol 2005; 16: v15\u2013v26.","journal-title":"Ann Oncol"},{"key":"BFbmt2008332_CR35","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2004.12.050","volume":"22","author":"P Corradini","year":"2004","unstructured":"Corradini P, Dodero A, Zallio F, Caracciolo D, Casini M, Bregni M et al. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells. J Clin Oncol 2004; 22: 2172\u20132176.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008332_CR36","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1200\/JCO.2007.14.1366","volume":"26","author":"S Le Gouill","year":"2008","unstructured":"Le Gouill S, Milpied N, Buzyn A, De Latour RP, Vernant JP, Mohty M et al. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire. J Clin Oncol 2008; 26: 2264\u20132271.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008332_CR37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/sj.bmt.1705036","volume":"36","author":"GG Wulf","year":"2005","unstructured":"Wulf GG, Hasenkamp J, Jung W, Chapuy B, Truemper L, Glass B . Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma. Bone Marrow Transplant 2005; 36: 271\u2013273.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008332_CR38","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1182\/blood.V108.11.3031.3031","volume":"108","author":"R Tanosaki","year":"2006","unstructured":"Tanosaki R, Kim S, Yamazaki S, Fukuda T, Mori S, Heike Y et al. A retrospective single institute analysis of 127 lymphoma patients who underwent allogeneic stem cell transplantation: impact on peripheral T-cell lymphoma (PTCL) including ATLL. Blood 2006; 108: 3031.","journal-title":"Blood"},{"key":"BFbmt2008332_CR39","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/blood.V108.11.3026.3026","volume":"108","author":"J Zain","year":"2006","unstructured":"Zain J, Palmer J, Tsai N, Popplewell L, Nadamanee A, Krishnan A et al. Clinical outcomes of patients with T cell NHL undergoing allogeneic stem cell transplant. Blood 2006; 108: 3026.","journal-title":"Blood"},{"key":"BFbmt2008332_CR40","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1182\/blood.V110.11.3040.3040","volume":"110","author":"HM O\u2019Leary","year":"2007","unstructured":"O\u2019Leary HM, Savage KJ, Toze CL, Connors JM, Gascoyne RD, Mourad YA et al. Allogeneic stem cell transplantation as treatment for relapsed and high-risk peripheral T-Cell lymphoma. Blood 2007; 110: 3040.","journal-title":"Blood"},{"issue":"S1","key":"BFbmt2008332_CR41","first-page":"S244","volume":"41","author":"A G\u00fcnther","year":"2008","unstructured":"G\u00fcnther A, Schade H, Humpe A, Gahn B, Claviez A, Schrauder A et al. BEAM-alemtuzumab followed by allogeneic SCT is a feasible and highly efficient treatment strategy in relapsed or refractory T-NHL. Bone Marrow Transplant 2008; 41 (S1): S244.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008332_CR42","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bbmt.2008.01.002","volume":"14","author":"M Hamadani","year":"2008","unstructured":"Hamadani M, Awan FT, Elder P, Lin TS, Porcu P, Blum KA et al. Allogeneic hematopoietic stem cell transplantation for peripheral T cell lymphomas: evidence of graft-versus-T cell lymphoma effect. Biol Blood Marrow Transplant 2008; 14: 480\u2013483.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008332_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00280-005-0136-y","volume":"58","author":"JG Kim","year":"2006","unstructured":"Kim JG, Sohn SK, Chae YS, Kim DH, Baek JH, Lee KB et al. CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas. Cancer Chemother Pharmacol 2006; 58: 35\u201339.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2 Suppl 2","key":"BFbmt2008332_CR44","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1053\/j.seminhematol.2005.12.010","volume":"43","author":"R Kurzrock","year":"2006","unstructured":"Kurzrock R, Ravandi F . Purine analogues in advanced T-cell lymphoid malignancies. Semin Hematol 2006; 43 (2 Suppl 2): S27\u2013S34.","journal-title":"Semin Hematol"},{"key":"BFbmt2008332_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/j.1365-2141.2007.06658.x","volume":"139","author":"OA O\u2019Connor","year":"2007","unstructured":"O\u2019Connor OA, Hamlin PA, Portlock C, Moskowitz CH, Noy A, Straus DJ et al. Pralatrexate, a novel class of antifol with high affinity for the reduced folate carrier-type 1, produces marked complete and durable remissions in a diversity of chemotherapy refractory cases of T-cell lymphoma. Br J Haematol 2007; 139: 425\u2013428.","journal-title":"Br J Haematol"},{"key":"BFbmt2008332_CR46","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1182\/blood-2007-02-074641","volume":"110","author":"A Gallamini","year":"2007","unstructured":"Gallamini A, Zaja F, Patti C, Billio A, Specchia MR, Tucci A et al. Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Blood 2007; 110: 2316\u20132323.","journal-title":"Blood"},{"issue":"1 Suppl 3","key":"BFbmt2008332_CR47","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1053\/j.seminoncol.2005.12.017","volume":"33","author":"F Foss","year":"2006","unstructured":"Foss F . Clinical experience with denileukin diftitox (ONTAK). Semin Oncol 2006; 33 (1 Suppl 3): S11\u2013S16.","journal-title":"Semin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008332","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008332.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:39:26Z","timestamp":1648035566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,20]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["BFbmt2008332"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.332","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,20]]},"assertion":[{"value":"8 July 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}